Sorrento Therapeutics sues Soon-Shiong over alleged cancer drug scheme
Biopharmaceutical company Sorrento Therapeutics Inc. has filed lawsuits against Dr. Patrick Soon-Shiong and his NantWorks network of companies, accusing the biotech entrepreneur of engaging in a “catch-and-kill” plan that ultimately blocked the release of Sorrento’s promising cancer drug.
In the lawsuits filed in Los Angeles Superior Court on Wednesday, San Diego-based Sorrento Therapeutics (Nasdaq: SRNE) is seeking damages of more than $1 billion through an arbitration complaint an d $90.05…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: I-Chun Chen Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Health Management | Lawsuits | Legislation | Pharmaceuticals